Supply, and everything around it.
From a single API line to a full technology transfer, BOOKPHARM covers the pharmaceutical supply chain end to end. For licensed companies only.
API & FDF supply
Active pharmaceutical ingredients, advanced intermediates and finished dosage forms, supplied to licensed manufacturers, distributors and importers with the regulatory documentation to support your filings.
CDMO / CMO
Contract development and manufacturing across small molecules and biologics, including a GCT (viral vector & cell therapy) end-to-end service: process development, scale-up, GMP manufacturing, analytical validation and CMC registration support.
Technology transfer
Registration and supply packages that move a product onto your site: biosimilar tech transfer, process validation and documentation, with API supply to match.
GMP & RA consulting
Regulatory affairs and GMP consulting for the EU, US, Brazil and Mexico markets, from dossier strategy to inspection readiness.
License-in / License-out (BD)
Business development across chemical and biological programs, from early clinical assets to approved products. Investigational programs are represented accurately and never implied to be approved.
International M&A consulting
Advisory for cross-border pharmaceutical transactions, drawing on a network of 200+ partners across 40+ countries.
Services delivered from our own facilities.
A Shanghai CMC arm for peptide process development and analytical work, and a 55,333 m² FDA-qualified production site in Chongqing for commercial manufacture.
Click any photo to view it full size.
17 programs available for licensing
12 chemical and 5 biological programs, spanning launched products through early clinical assets. Many are investigational and are labeled by development stage; none are implied to be approved. Contact us for the current BD list under confidentiality.